Indacaterol thalin 20-lyase and 17α-hydroxylase with IC50

20-lyase and 17α-hydroxylase with IC50 of 27 and 30 nM respectively

Voxelotor (GBT440

Poliumoside exhibits greater inhibitory effects on rat lens aldose reductase(RLAR) with IC50 values of 8

once daily

CAS Number: 677331-12-3

Indacaterol thalin 20-lyase and 17α-hydroxylase with IC50Indacaterol is an ultra long acting beta adrenoceptor agonist developed by Novartis. It was approved by the European Medicines Agency (EMA) under the trade name Onbrez on November 30, 2009, and by the United States Food and Drug Administration (FDA), under the trade name Arcapta Neohaler, on July 1, 2011. It needs to be taken only once a day, unlike the related drugs formoterol and salmeterol. It is licensed only for the treatment of chronic